Gates Foundation
LumiraDx Gets $14.2M in Gates Foundation Grants to Develop Point-of-Care Molecular TB Test
The test, which is being designed for use with the company's LumiraDx point-of-care platform, would be the first molecular test to run on the system.
Sherlock Biosciences Awarded $2M by Gates Foundation for Instrument-Free Diagnostics
The funding will be used to advance the firm's assay menu as well as to develop an integrated prototype diagnostic device.
Gates Foundation Gifts Cardea Bio $1.1M to Develop Infectious Disease Breath Tests
The project is intended to demonstrate the feasibility of Cardea's biosignal processing unit test to detect odors for the diagnosis of infectious diseases.
FIND Intensifies Efforts to Help Countries Determine Best Options for Their Diagnostic Needs
Premium
FIND plans to expand its activities around its diagnostic network optimization process, including the use of its OptiDx platform, to 15 more countries.
Global Access Health Acquires Rapid Test Firm Mologic; Invests at Least $41M in Deal
As part of the transaction Global Access Health will acquire all of Mologic's shares and integrate both Mologic and a sister entity, Global Access Diagnostics.
Feb 6, 2019
OraSure Technologies Q4 Revenues Down 3 Percent
Feb 8, 2018
OraSure Q4 Revenues Spike 46 Percent
Dec 27, 2016